Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
ATLANTHERA logo — Bone targeted delivery concept

ATLANTHERA

Bone targeted delivery concept

Founded 2011 France France 8 employees Venture round Total: $800.00K Health and Wellness

General Information

Company Name ATLANTHERA
Founded Year 2011
Location France France
Employees 8
Industries Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with ATLANTHERA. To contact ATLANTHERA, visit atlanthera.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ATLANTHERA compare?

A PDF of ATLANTHERA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ATLANTHERA soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ATLANTHERA

ATLANTHERA is a drug discovery company with a focus on bone diseases and bone cancer treatments. The company's slogan is "Bone targeted delivery concept," which aligns with its vision to be the leader in bone-targeted drug delivery to cure bone cancer and metastases. Founded in 2011 and headquartered in France, Atlanthera boasts a highly qualified team and a worldwide-known experts network. Their concept revolves around bone-targeted delivery of anti-cancer drugs. The last investment of €800.00K came in the form of a Venture Round investment on 15 April 2014, with Go Capital being the investor. For more information, visit their website www.atlanthera.com or watch their concept video at https://youtu.be/m3BBWguO6hs.

Business keywords: Drug Discovery, Therapeutic Approaches, Bone-targeted Drug Delivery, Bone Tumors, Cancer Treatments, Metastases, Research and Development, Oncology, Medical Innovation

Services & Products

Development of novel therapies for bone and joint diseases
custom drug conjugation
targeted drug delivery
drug vectorization

Target Customers

Patients with bone and joint diseases such as osteosarcoma osteoarthritis and bone metastases from various primary cancers oncologists orthopedic specialists

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €800.00K 1
Go Capital
Go Capital
15 Apr 2014

ATLANTHERA Alternatives & Competitors

View All Alternatives
ATLANTHERA vs
Probmet Therapeutics
Probmet Therapeutics Denmark

An oncology therapeutics company developing new targeted treatments for breast cancer brain metastat...

Convertible Note
2 employees
Health Care, Health and Wellness
ATLANTHERA vs
Avenzo Therapeutics
Avenzo Therapeutics United States

Developing the next generation of oncology therapies for patients

61 employees
Biotechnology, Health Care
ATLANTHERA vs
Kelonia Therapeutics
Kelonia Therapeutics United States

Revolutionizing in vivo gene delivery to usher in a new era of genetic medicines.

Private Equity
74 employees
Biotechnology, Health Care
View all alternatives

FAQ About ATLANTHERA

Bone targeted delivery concept
ATLANTHERA was founded in 2011.
ATLANTHERA is headquartered in France.
ATLANTHERA operates in Health and Wellness. Its work centres on Drug Discovery, Therapeutic Approaches, Bone-targeted Drug Delivery and Bone Tumors. Its customers include Patients with bone and joint diseases such as osteosarcoma, osteoarthritis and and bone metastases from various primary cancers.
ATLANTHERA has approximately 8 employees.
ATLANTHERA has completed 1 funding round, raising a total of $800.00K. The latest funding stage is Venture round.
ATLANTHERA offers: Development of novel therapies for bone and joint diseases, custom drug conjugation, targeted drug delivery, drug vectorization.
Top alternatives and competitors to ATLANTHERA include Probmet Therapeutics, Avenzo Therapeutics, Kelonia Therapeutics, AC BioScience SA, Sumitomo Pharma Oncology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ATLANTHERA and Probmet Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ATLANTHERA, https://bouncewatch.com/company/atlanthera, updated 11 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes